CRY - CryoLife, Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 968.35M |
| Enterprise value 3 | 1.18B |
| Trailing P/E | 586.82 |
| Forward P/E 1 | 66.21 |
| PEG ratio (5-yr expected) 1 | 3.10 |
| Price/sales (ttm) | 3.53 |
| Price/book (mrq) | 3.49 |
| Enterprise value/revenue 3 | 4.29 |
| Enterprise value/EBITDA 6 | 39.00 |
Trading information
Stock price history
| Beta (5Y Monthly) | 0.66 |
| 52-week change 3 | -6.16% |
| S&P500 52-week change 3 | 24.46% |
| 52-week high 3 | 33.00 |
| 52-week low 3 | 20.76 |
| 50-day moving average 3 | 24.25 |
| 200-day moving average 3 | 26.95 |
Share statistics
| Avg vol (3-month) 3 | 207.73k |
| Avg vol (10-day) 3 | 187.12k |
| Shares outstanding 5 | 37.5M |
| Float | 35.96M |
| % held by insiders 1 | 3.82% |
| % held by institutions 1 | 72.14% |
| Shares short (29 Nov 2019) 4 | 991.58k |
| Short ratio (29 Nov 2019) 4 | 4.8 |
| Short % of float (29 Nov 2019) 4 | 3.26% |
| Short % of shares outstanding (29 Nov 2019) 4 | 2.64% |
| Shares short (prior month 31 Oct 2019) 4 | 916.78k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.03 |
| Trailing annual dividend yield 3 | 0.12% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Dec 2015 |
| Ex-dividend date 4 | 9 Dec 2015 |
| Last split factor (new per old) 2 | 2/3 |
| Last split date 3 | 28 Dec 2000 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2018 |
| Most-recent quarter (mrq) | 30 Sep 2019 |
Profitability
| Profit margin | 0.59% |
| Operating margin (ttm) | 5.90% |
Management effectiveness
| Return on assets (ttm) | 1.74% |
| Return on equity (ttm) | 0.59% |
Income statement
| Revenue (ttm) | 274.32M |
| Revenue per share (ttm) | 7.42 |
| Quarterly revenue growth (yoy) | 5.10% |
| Gross profit (ttm) | 175.78M |
| EBITDA | 30.17M |
| Net income avi to common (ttm) | 1.61M |
| Diluted EPS (ttm) | 0.04 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 36.69M |
| Total cash per share (mrq) | 0.98 |
| Total debt (mrq) | 245.03M |
| Total debt/equity (mrq) | 88.30 |
| Current ratio (mrq) | 4.30 |
| Book value per share (mrq) | 7.40 |
Cash flow statement
| Operating cash flow (ttm) | 25.29M |
| Levered free cash flow (ttm) | 5.65M |